How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

A new large study from Denmark finds no evidence that aluminum salts used in vaccines are tied to a higher risk of childhood ...

Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...

Under the agreement, Allarity will supply advanced transcriptome analysis services to support the partner’s efforts to ...

Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it ...

A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...

Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a differentiated ...

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...